These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab. Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317 [No Abstract] [Full Text] [Related]
6. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa. Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950 [No Abstract] [Full Text] [Related]
7. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Moschella SL Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525 [TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Mekkes JR; Bos JD Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504 [TBL] [Abstract][Full Text] [Related]
9. Etanercept for the treatment of hidradenitis suppurativa. Sotiriou E; Apalla Z; Ioannidos D Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548 [No Abstract] [Full Text] [Related]
10. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy. Arenbergerova M; Gkalpakiotis S; Arenberger P Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684 [TBL] [Abstract][Full Text] [Related]
11. Current and emerging nonsurgical treatment options for hidradenitis suppurativa. Kerdel FA Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460 [TBL] [Abstract][Full Text] [Related]
12. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab. Nuño-González A; Dehesa L; Ricotti C; Kerdel F Actas Dermosifiliogr; 2012 Dec; 103(10):936-7. PubMed ID: 23149048 [No Abstract] [Full Text] [Related]
13. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy. Roussomoustakaki M; Dimoulios P; Chatzicostas C; Kritikos HD; Romanos J; Panayiotides JG; Kouroumalis EA J Gastroenterol; 2003; 38(10):1000-4. PubMed ID: 14614610 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. Rosi YL; Lowe L; Kang S J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171 [TBL] [Abstract][Full Text] [Related]
15. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of infliximab in the treatment of follicular occlusion triad]. Deschamps ME; Payet S; Tournadre A; Soubrier M; Souteyrand P; D'Incan M Ann Dermatol Venereol; 2010; 137(8-9):546-50. PubMed ID: 20804900 [TBL] [Abstract][Full Text] [Related]
17. Moderate to severe hidradenitis suppurativa treated with biological therapies. Chinniah N; Cains GD Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051 [TBL] [Abstract][Full Text] [Related]